HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
Pralatrexate
Description
Pralatrexate is an antimetabolite for the treatment of relapsed or refractory peripheral T-cell lymphoma. It is more efficiently retained in cancer cells than methotrexate. FDA approved on September 24, 2009.
No brand information found.
